Transcatheter aortic valve implantation: The procedure

Heart

Volumn 98, Issue SUPPL. 4, 2012, Pages

  Stortecky, Stefan ^a   Buellesfeld, Lutz ^a   Wenaweser, Peter ^a   Windecker, Stephan ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AXILLARY ARTERY; BALLOON DILATATION; CATHETER; DISEASE SEVERITY; FEMORAL VEIN; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HUMAN; MINIMALLY INVASIVE PROCEDURE; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUBCLAVIAN ARTERY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TREATMENT PLANNING; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN;

EID: 84869055716     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302401     Document Type: Review

References (30)

1. Lababidi Z. Aortic balloon valvuloplasty. Am Heart J 1983;106 :751-2.
2. Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986;1:63-7.
3. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991;84:2383-97.
4. Eltchaninoff H, Cribier A, Tron C, et al. Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. Eur Heart J 1995;16:1079-84.
5. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642-50.
6. Sack S, Kahlert P, Khandanpour S, et al. Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol 2008;97:288-97.
7. Saia F, Marrozzini C, Moretti C, et al. The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention 2011;7:723-9.
8. Daly MJ, Monaghan M, Hamilton A, et al. Short-term efficacy of palliative balloon aortic valvuloplasty in selected patients with high operative risk. J Invasive Cardiol 2012;24:58-62.
9. Davidavicius G, Chieffo A, Shannon J, et al . A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing transcatheter aortic valve implantation (TAVI): is it a valid alternative to rapid pacing? A prospective pilot study. J Invasive Cardiol 2011;23:467-71.
10. Laynez A, Ben-Dor I, Hauville C, et al. Frequency of cardiac conduction disturbances after balloon aortic valvuloplasty. Am J Cardiol 2011;108:1311-15.
11. Grube E, Naber C, Abizaid A, et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 2011;4:751-7.
12. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50.
13. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616 -24.
14. Haas PC, Krajcer Z, Diethrich EB. Closure of large percutaneous access sites using the Prostar XL Percutaneous Vascular Surgery device. J Endovasc Surg 1999;6:168-70.
15. Cockburn J, de Belder A, Brooks M, et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the prostar system in 118 cases. Catheter Cardiovasc Interv 2012;79:143-9.
16. Sharp AS, Michev I, Maisano F, et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010;75:784-93.
17. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591-6.
18. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
19. Bojara W, Mumme A, Gerckens U, et al. Implantation of the CoreValve self-expanding valve prosthesis via a subclavian artery approach: a case report. Clin Res Cardiol 2009;98 :201-4.
20. Ruge H, Lange R, Bleiziffer S, et al. First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report. Heart Surg Forum 2008;11:E323-4.
21. Wenaweser P, Pilgrim T, Roth N, et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 2011;161:1114-24.
22. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010;3:359-66.
23. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv 2010;75:1129-36.
24. Bruschi G, De Marco F, Fratto P, et al. Direct aortic access through right minithoracotomy for implantation of self-expanding aortic bioprosthetic valves. J Thorac Cardiovasc Surg 2010;140:715-17.
25. Bapat V, Thomas M, Hancock J, et al. First successful trans-catheter aortic valve implantation through ascending aorta using Edwards SAPIEN THV system. Eur J Cardiothorac Surg 2010;38:811-13.
26. Rodes-Cabau J, Gutierrez M, Bagur R, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011;57:1988-99.
27. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.
28. Kempfert J, Rastan AJ, Beyersdorf F, et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur J Cardiothorac Surg 2011;40:1114-9.
29. Vergnat M, Henaine R, Kalejs M, et al. A new self-expanding aortic stent valve with annular fixation: in vitro haemodynamic assessment. Eur J Cardiothorac Surg 2009;35:970-5; discussion 5-6.
30. Kempfert J, Rastan AJ, Mohr FW, et al. A new self-expanding transcatheter aortic valve for transapical implantation-first in man implantation of the JenaValve. Eur J Cardiothorac Surg 2011;40:761-3.